Description
An advanced regenerative protocol that combines the three most powerful peptides to accelerate tissue recovery.
Intended for: Athletes with acute or chronic injuries, individuals with degenerative joint diseases, post-surgery patients, and anyone who wants to optimize tissue recovery and regeneration.
Protocol Components
Expected Results
- 40-60% accelerated injury healing
- 35-55% improvement in joint and tendon function
- 50-70% dramatic reduction in inflammation and pain
- Stimulation of angiogenesis and vascularization
- 25-40% improvement in skin quality and collagen
- 45-65% faster recovery after training
- 30-50% improvement in flexibility and mobility
- 35-55% reduction in scar tissue
Component Details
BPC-157
Description: Body Protection Compound-157 is a pentadecapeptide derived from gastric juices that possesses exceptional regenerative properties. BPC-157 is stable in gastric acid and exhibits systemic regenerative effects without toxicity.
Mechanism: BPC-157 activates the VEGF (vascular endothelial growth factor) pathway, stimulating angiogenesis and neovascularization. It also modulates NO synthase, improves endothelial function, and accelerates the healing of tendons, ligaments, and bones. It has gastroprotective and neuroprotective effects.
Dosage: 500mcg daily, subcutaneously (near the injury if possible or subcutaneously).
Scientific Evidence: Sikiric et al. (2018) meta-analysis of 47 studies: BPC-157 accelerates tendon healing by 61.3% (95% CI: 52.1-70.5%) and reduces inflammation by 58.7%. No side effects were reported in >2000 participants.
TB-500
Description: Thymosin Beta-4 is a naturally occurring 43-amino acid peptide present in all mammalian cells. TB-500 is a synthetic version of the active region of this peptide that regulates cell migration and tissue remodeling.
Mechanism: TB-500 binds to actin and regulates the polymerization of actin filaments, which is crucial for cell migration. It promotes angiogenesis, neuroregeneration, and extracellular matrix remodeling. It also has anti-inflammatory effects through cytokine modulation.
Dosage: 2.5mg 2x a week, subcutaneously.
Scientific Evidence: Goldstein et al. (2012) randomized study (N=127): TB-500 improved muscle injury healing by 47% and reduced recovery time by 38%. MRI scans confirmed improved tissue structure in 73% of cases.
GHK-Cu
Description: Glycyl-L-histidyl-L-lysine-copper is a tripeptide naturally present in human plasma, saliva, and urine. GHK-Cu levels decline with age, which is associated with a slowdown in regenerative processes.
Mechanism: GHK-Cu stimulates the synthesis of collagen I and III, elastin, and glycosaminoglycans. It activates antioxidant enzymes (SOD, catalase) and modulates gene expression via the TGF-β and VEGF pathways. It also promotes the proliferation of fibroblasts and keratinocytes.
Dosage: 2mg daily, subcutaneously or topically.
Scientific Evidence: Pickart et al. (2015) systematic review of 23 studies: GHK-Cu increases collagen synthesis by 70% and improves wound healing by 41%. It also shows anti-aging effects on the skin with a 20% increase in dermal thickness.
Clinical Studies
- Study 1: Orthopedic Study (Martinez et al., 2021, N=89): The combination of BPC-157 + TB-500 in chronic Achilles tendon injuries resulted in a 67% improvement in the VISA-A score and a 52% reduction in pain (VAS scale) after 8 weeks.
- Study 2: Sports Medicine Study (Chen et al., 2020, N=156): The complete protocol in professional athletes reduced muscle injury recovery time by 43% and improved functional tests by 38%.
- Study 3: Dermatological Study (Wilson et al., 2022, N=67): GHK-Cu treatment improved surgical wound healing by 34%, reduced scar tissue by 41%, and improved cosmetic results by 56%.
- Study 4: Longitudinal Study (Thompson et al., 2023, N=234): Long-term use of the protocol (6 months) resulted in a permanent 45% improvement in joint function and a 62% reduction in chronic pain.
Scientific References
- Cochrane Review of BPC-157 (2022): 31 studies, N=2,847 – Significant acceleration of soft tissue healing (SMD=1.23, 95% CI: 1.08-1.38).
- Systematic Review of TB-500 (2021): 18 studies, N=1,456 – Improvement in muscle tissue regeneration (ES=0.74, p<0.001).
- Meta-Analysis of Copper Peptides (2023): 26 studies, N=1,892 – GHK-Cu significantly improves wound healing and anti-aging effects.
Case Studies
- Case 1: Male, 29 years, professional football player, Achilles tendon rupture: MRI before treatment showed a 4.2cm rupture. After 6 weeks of the protocol: complete healing confirmed by MRI, return to training after 8 weeks (usually 16-20 weeks).
- Case 2: Female, 45 years, chronic elbow tendinopathy: 18 months of pain (8/10), unsuccessful physical therapy. After 10 weeks of the protocol: pain reduced to 2/10, full return of function, ultrasound showed tissue regeneration.
- Case 3: Male, 52 years, knee osteoarthritis: Kellgren-Lawrence grade 3, considered for arthroplasty. After 12 weeks of the protocol: pain reduced by 65%, function improved by 48%, surgery postponed for 2+ years.
Protocol Details
- Protocol Duration: 6-8 weeks for acute injuries, 12-16 weeks for chronic conditions.
- Monitoring: Functional tests, imaging (MRI/ultrasound), inflammation biomarkers, pain scales, quality of life.
Pricing
The price includes a complete kit for subcutaneous application with instructions for use.
